A debate titled “How to Defeat Aging” will be held on May 27, 2024, featuring two distinguished scientists, Peter Fedichev and Aubrey de Grey, both proponents of radical life extension with biotechnology, with opposing views. Fedichev believes aging is irreversible but can be slowed or stopped,

John Hancock, along with its Toronto-based parent company Manulife (NYSE:MFC), today announced a five-year, multimillion-dollar research collaboration with the Massachusetts Institute of Technology (MIT) AgeLab, a multi-disciplinary research institute that works with business, government, and NGOs, leading innovation and research to help improve the quality of

LongX, an initiative dedicated to providing early-career avenues into longevity, announced a call for applications for its 2024 Xplore Program. The program lasts from June 2024 until September 2024 and features a one-month longevity primer course followed by the opportunity to gain educational experience with a

Berlin’s event landscape is growing: Longevity Week will take place in the German capital for the first time from May 6-12, 2024. The opening event will take place on May 6th at the Langenbeck-Virchow-Haus in Berlin Mitte near the Charité hospital. A total of 15 events

SynBioBeta, the leading community of entrepreneurs, investors, innovators, and biological engineers, today announced details for its flagship SynBioBeta 2024 conference. The premier annual event for the synthetic biology industry will be held May 6-9, 2024, in San Jose, gathering an estimated 2,000 attendees from around the

As the conference season kicks off, VC investors are gearing up for a cautiously optimistic 2024, where the normalization of valuations stands out as a positive trend. However, a growing concern shows over the potential impact of geopolitical conflicts and climate change pressures on this year’s

Following the resounding success of the Longevity Investors Lunch held during the World Economic Forum in Davos in January, Longevity Investors is thrilled to unveil the upcoming Longevity Investors Conference 2024. Set against the picturesque backdrop of Gstaad, Switzerland, the conference is scheduled to take place

Hevolution announced its investment of $20 million (SAR 75,000,000) as the lead investor for a $50 million (SAR 188,000,000) Series A financing extension in Aeovian Pharmaceuticals. Hevolution’s investment will advance promising therapies that target the mTORC1 biological pathway, helping find solutions to major unmet medical needs

Reservoir Neuroscience announced today the completion of a $4M financing round to support its development of new therapies for neurodegenerative diseases. Reservoir will use the funds to develop its novel class of drug compounds designed to restore health to the brain’s blood vessels in order to

Ora Biomedical, a pharmaceutical company that is pioneering novel small molecules to maximize healthy lifespan for humans and companion pets, is excited to announce its strategic collaboration with lifespan.io as the official charity partner for the Million-Molecule Challenge. The Million-Molecule Challenge, hosted by Ora Biomedical, is

The LBF community is dedicated to maximally accelerating progress in longevity. While the field has seen substantial advances in the past decade, there are clear and systemic deficiencies that have received little attention but retard progress for many. To coordinate efforts and identify the highest leverage

A group of award-winning filmmakers, longevity experts, and blockchain developers have come together to launch JellyfishDAO, a new decentralized autonomous organization (DAO) focused on funding and distributing movies and TV shows related to extending health and lifespan. “We created JellyfishDAO to shift the narrative around longevity

Vitalia is a new venture that aims to redefine the longevity biotech landscape, fostering drug development at warp speed: 4 months to get to market, instead of 10+ years. From January 6 to March 1, Vitalia will be hosting a two-month pop-up city experience similar to